Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
3.020
+0.440 (17.05%)
Jan 23, 2025, 12:26 PM EST - Market open
Compass Therapeutics Employees
Compass Therapeutics had 32 employees as of December 31, 2023. The number of employees increased by 6 or 23.08% compared to the previous year.
Employees
32
Change (1Y)
6
Growth (1Y)
23.08%
Revenue / Employee
$26,563
Profits / Employee
-$1,492,406
Market Cap
415.52M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 32 | 6 | 23.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | -7 | -22.58% |
| Dec 31, 2020 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
CMPX News
- 6 weeks ago - Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer - GlobeNewsWire
- 6 weeks ago - Compass Therapeutics: Near-Term Readout, But Beware The High Stakes In Biliary Cancer - Seeking Alpha
- 7 weeks ago - Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Compass Therapeutics to Participate in Upcoming Investor Events - GlobeNewsWire
- 2 months ago - Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire
- 3 months ago - Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - GlobeNewsWire
- 6 months ago - Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference - GlobeNewsWire